Mirogabalin and emerging therapies for diabetic neuropathy

There are currently no approved disease-modifying therapies for diabetic neuropathy, and there are only 3 US Food and Drug Administration-approved therapies (pregabalin, duloxetine, and tapentadol) for painful diabetic neuropathy. They each have moderate efficacy with adverse effects limiting optima...

Descripción completa

Detalles Bibliográficos
Autores principales: Javed, Saad, Alam, Uazman, Malik, Rayaz A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110292/
https://www.ncbi.nlm.nih.gov/pubmed/30174455
http://dx.doi.org/10.2147/JPR.S145999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110292/
https://www.ncbi.nlm.nih.gov/pubmed/30174455
http://dx.doi.org/10.2147/JPR.S145999

Ejemplares similares